Search

Search Constraints

You searched for: Author/Creator Frolova, Olga

Search Results

5. SL‐401 and SL‐501, targeted therapeutics directed at the interleukin‐3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia. (19th June 2014)